New Resorbable Bioceramic Materials for Bone Fractures Might Soon Enter the Market
RESTORATION, an European research project, has developed new resorbable bioceramic materials that can be used in three different cases: the mandible, the vertebrae and the knees. Thanks to the excellent project results, these products might be available on the market within a few years.
The European research project RESTORATION developed new resorbable ceramic biocomposites for orthopaedic and maxillofacial applications. These products can mimic the structure of bones and can be designed to closely match the mechanical requirements of the implant sites. In addition, some of the bioceramics are bioactive, which means they can be fully absorbed by the body.
The project is now coming to an end but some partners will exploit the project results and bring these new technologies to the market in the coming years. Depending on further progress, JRI Orthopaedics might create a spin-off for the industrial scale-up of products developed within the project. This is the case for a bioceramic material to be used as a bone filler, and a 3D printed plug to treat osteochondral defects. In parallel, Sagetis Biotech developed a polymer paste and Bionica Tech/COREP an osteoinductive composite cement called Spine-Ghost, both to be injected into broken vertebrae. Other technologies are in an earlier development stage and further research needs to be done to reach commercialisation. This is the case for a novel plate design for maxillofacial fracture fixation, and for an injectable material for osteochondral repair.
Kenny Dalgarno, Professor at Newcastle University and project coordinator says: ”The project has been a real success; all the partners have different interests in terms of exploitation but they benefited from the expertise of the others and developed strong research and business partnerships.”
The project involves over a 4-year period following organisations: Newcastle University (project coordinator), JRI Orthopaedics , Sagetis Biotech , Universidade de Évora , Orla Protein Technologies , LEITAT , Karolinska Institutet , Bionica Tech /Corep, Institut Quimic de Sarria , Glass Technology Services , and FPO .
Watch the project video https://vimeo.com/157420641
This project has received funding from the European Union's Seventh Programme for research, technological development and demonstration under grant agreement No 280575.
This publication reflects only the author’s views and that the European Union is not liable for any use that may be made of the information contained therein.
Max Viallon, +34 93 788 23 00
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
SMITHS-DETECTION18.7.2018 11:07 | pressemeddelelse
Smiths Detection Technology Chosen for Standard 3 Upgrade at Helsinki Airport
NORSK-TITANIUM18.7.2018 09:02 | pressemeddelelse
Norsk Titanium Continues to Grow in the State of New York
FRVR18.7.2018 09:02 | pressemeddelelse
FRVR skaffer 3 millioner dollars, anført af Accel, til at bygge og distribuere spil til spillere på alle platforme.
EUSA-PHARMA18.7.2018 08:02 | pressemeddelelse
EUSA Pharma Announces Acquisition of Global Rights to SYLVANT® (siltuximab) from Janssen Sciences Ireland UC for $115 Million
THRIVETRACKER18.7.2018 08:02 | pressemeddelelse
The Best User Interface in Mobile and Web Tracking Just got Better
JPMORGAN-CHASE17.7.2018 21:42 | pressemeddelelse
JPMorgan Chase Bank announces the placement of cash-settled exchangeable bonds into Ping An Insurance (Group) Company of China Limited due 2020
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum